Introducing VECSEL Technology to the Modulight ML6600 Platform for Quantum Applications
Introducing VECSEL Technology to the Modulight ML6600 Platform for Quantum Applications Read More »
Introducing VECSEL Technology to the Modulight ML6600 Platform for Quantum Applications Read More »
Modulight proudly announces new variants of its ML6600 platform, designed specifically for the demanding requirements of microscopy illumination, such as super-resolution microscopy. These advanced solutions support both single-wavelength and multi-wavelength configurations, tailored to meet diverse customer needs in imaging applications. ML6600 platform provides all key wavelengths for microscopy—for example 355nm, 405 nm, 488 nm, 532nm, 561 nm, and 638 nm.
ML6600-based Laser Solutions for Microscopy Read More »
Modulight 632.8 nm DBR laser: A Superior Alternative to Traditional HeNe lasers Read More »
1762 nm Fiber Laser on the ML6600 Platform for Barium Ion Manipulation Read More »
Modulight announces a significant contribution to the field of cancer treatment through the publication of a comprehensive review on Photodynamic Therapy (PDT) in Nature Reviews Bioengineering: “Engineering Photodynamics for Treatment, Priming, and Imaging”.
Photodynamic Therapy for Cancer Treatment – Review Article by Nature Read More »
ML6600 Narrow linewidth VECSEL for photoionization of Ba for trapped ion computing Read More »
Modulight achieved the international ISO 27001 information security standard certification today on February 28, 2024. The certification of the information security management system demonstrates the organization’s commitment to protecting information and managing high-level of information security. “We are expanding the use of cloud services in accordance with our SaaS business model and are making strong
ISO 27001 – information security standard for Modulight Read More »
Modulight is pleased to announce its participation in the GlioLighT project, aimed at developing new treatment options for gliomas. This project has received substantial funding of approximately EUR 2.2 million over three years from the European Innovation Council’s Pathfinder program. The GlioLighT project partners include Johannes Gutenberg University Mainz, Aston University in Birmingham, the University
Modulight Announces Involvement in GlioLighT Project for Glioma Treatment Read More »